Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS ...

Novartis to buy Regulus for $0.8 billion upfront with potential for $1.7B total based on ADPKD drug milestone; deal set to ...

The pharma will pay $800 million for the biotech, which was launched nearly two decades ago by Alnylam and Ionis to advance ...

Researchers at Karolinska Institutet and Uppsala University have developed a powerful new technique to better understand how ...

Over the last 7 days, the United States market has risen by 7.1%, with a 12-month increase of 7.7% and earnings forecasted to grow by 14% annually. In light of these conditions, investors may find ...

Regulus Therapeutics Inc.’s RGLS share price has surged by 25.87%, which has investors questioning if this is right time to ...

Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer ...